About Crux Biomedical
Crux Biomedical is a company based in Menlo Park (United States) founded in 2004 was acquired by Volcano in December 2012.. Crux Biomedical has raised $8 million across 1 funding round from investors including Volcano and Alloy Ventures. Crux Biomedical operates in a competitive market with competitors including BTG International, Pulnovo Medical, SoniVie, Aria CV and Adient Medical, among others.
- Headquarter Menlo Park, United States
-
Sectors
Healthcare
-
Phone
*********
-
Website
*********
-
Social
*********
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Funding Insights of Crux Biomedical
Crux Biomedical has successfully raised a total of $8M through 1 strategic funding round. The most recent funding activity was a Series B round of $8 million completed in January 2009. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 1
- Last Round Series B — $8.0M
-
First Round
First Round
(22 Jan 2009)
- Investors Count 1
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jan, 2009 | Amount | Series B - Crux Biomedical | Valuation |
investors |
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in Crux Biomedical
Crux Biomedical has secured backing from 2 investors, including venture fund investors. Prominent investors backing the company include Volcano and Alloy Ventures. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Early stage venture capital firm investing in the US
|
Founded Year | Domain | Location | |
|
Products for vascular imaging and peripheral therapeutics are provided.
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by Crux Biomedical
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - Crux Biomedical
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Crux Biomedical Comparisons
Competitors of Crux Biomedical
Crux Biomedical operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as BTG International, Pulnovo Medical, SoniVie, Aria CV and Adient Medical, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Therapeutics are developed for oncology, pulmonology, hematology, and anti-venom treatments.
|
|
| domain | founded_year | HQ Location |
A medical device for pulmonary hypertension treatment is developed.
|
|
| domain | founded_year | HQ Location |
A denervation catheter for pulmonary hypertension treatment is developed.
|
|
| domain | founded_year | HQ Location |
Device for pulmonary hypertension
|
|
| domain | founded_year | HQ Location |
Bioabsorbable medical devices are developed for pulmonary embolism prevention.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Crux Biomedical
Frequently Asked Questions about Crux Biomedical
When was Crux Biomedical founded?
Crux Biomedical was founded in 2004 and raised its 1st funding round 5 years after it was founded.
Where is Crux Biomedical located?
Crux Biomedical is headquartered in Menlo Park, United States. It is registered at Menlo Park, California, United States.
Is Crux Biomedical a funded company?
Crux Biomedical is a funded company, having raised a total of $8M across 1 funding round to date. The company's 1st funding round was a Series B of $8M, raised on Jan 22, 2009.
What does Crux Biomedical do?
Crux Biomedical developed a vena cava filter - a type of retrievable vascular filter, that is implanted by interventional radiologists or vascular surgeons into the vena cava to presumably prevent life-threatening pulmonary emboli. USP is a unique self-centering helical design and can be deployed and retrieved through jugular or femoral vessels. Received CE Mark in December 2011 and 510(k) clearance in July 2012. Crux was acquired by Volcano in 2012.
Who are the top competitors of Crux Biomedical?
Crux Biomedical's top competitors include Pulnovo Medical, SoniVie and BTG International.
Who are Crux Biomedical's investors?
Crux Biomedical has 2 investors. Key investors include Volcano, and Alloy Ventures.